塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/07/11 | 5,995 | 6,033 | 5,962 | 5,995 | -9 | -0.1% | 1,183,900 |
2017/07/10 | 6,050 | 6,050 | 5,971 | 6,004 | -24 | -0.4% | 989,400 |
2017/07/07 | 6,070 | 6,074 | 5,988 | 6,028 | -20 | -0.3% | 1,136,100 |
2017/07/06 | 6,175 | 6,177 | 6,025 | 6,048 | -89 | -1.5% | 1,692,300 |
2017/07/05 | 6,225 | 6,229 | 6,124 | 6,137 | -59 | -1% | 750,200 |
2017/07/04 | 6,169 | 6,214 | 6,163 | 6,196 | +28 | +0.5% | 1,049,900 |
2017/07/03 | 6,205 | 6,230 | 6,165 | 6,168 | -91 | -1.5% | 1,166,500 |
2017/06/30 | 6,224 | 6,265 | 6,190 | 6,259 | -17 | -0.3% | 1,023,200 |
2017/06/29 | 6,300 | 6,318 | 6,267 | 6,276 | +11 | +0.2% | 1,003,100 |
2017/06/28 | 6,295 | 6,314 | 6,255 | 6,265 | -49 | -0.8% | 877,400 |
2017/06/27 | 6,419 | 6,433 | 6,304 | 6,314 | -105 | -1.6% | 1,310,900 |
2017/06/26 | 6,325 | 6,422 | 6,313 | 6,419 | +84 | +1.3% | 667,200 |
2017/06/23 | 6,339 | 6,360 | 6,321 | 6,335 | +40 | +0.6% | 749,700 |
2017/06/22 | 6,343 | 6,345 | 6,289 | 6,295 | +13 | +0.2% | 973,300 |
2017/06/21 | 6,276 | 6,307 | 6,244 | 6,282 | +5 | +0.1% | 1,143,200 |
2017/06/20 | 6,286 | 6,324 | 6,271 | 6,277 | -7 | -0.1% | 994,100 |
2017/06/19 | 6,170 | 6,287 | 6,170 | 6,284 | +126 | +2% | 1,458,200 |
2017/06/16 | 6,100 | 6,180 | 6,082 | 6,158 | +91 | +1.5% | 1,731,200 |
2017/06/15 | 5,969 | 6,080 | 5,963 | 6,067 | +98 | +1.6% | 1,232,000 |
2017/06/14 | 5,965 | 6,000 | 5,927 | 5,969 | +44 | +0.7% | 1,270,100 |
2017/06/13 | 5,880 | 5,934 | 5,857 | 5,925 | +35 | +0.6% | 1,301,800 |
2017/06/12 | 5,881 | 5,924 | 5,863 | 5,890 | -30 | -0.5% | 1,119,600 |
2017/06/09 | 5,921 | 5,936 | 5,901 | 5,920 | +10 | +0.2% | 2,321,000 |
2017/06/08 | 5,908 | 5,923 | 5,892 | 5,910 | -12 | -0.2% | 1,075,300 |
2017/06/07 | 5,929 | 5,942 | 5,898 | 5,922 | +8 | +0.1% | 1,200,800 |
2017/06/06 | 5,931 | 5,945 | 5,890 | 5,914 | -54 | -0.9% | 1,107,500 |
2017/06/05 | 5,900 | 5,992 | 5,882 | 5,968 | +39 | +0.7% | 1,010,000 |
2017/06/02 | 5,985 | 5,991 | 5,922 | 5,929 | -61 | -1% | 1,619,700 |
2017/06/01 | 5,900 | 6,015 | 5,900 | 5,990 | +71 | +1.2% | 1,203,200 |
2017/05/31 | 5,948 | 5,997 | 5,919 | 5,919 | -68 | -1.1% | 1,552,500 |
2017/05/30 | 6,032 | 6,052 | 5,980 | 5,987 | -56 | -0.9% | 644,000 |
2017/05/29 | 6,086 | 6,093 | 6,043 | 6,043 | +16 | +0.3% | 751,800 |
2017/05/26 | 6,105 | 6,123 | 6,027 | 6,027 | -74 | -1.2% | 779,000 |
2017/05/25 | 6,049 | 6,129 | 6,049 | 6,101 | +16 | +0.3% | 729,400 |
2017/05/24 | 6,115 | 6,116 | 6,066 | 6,085 | +19 | +0.3% | 825,300 |
2017/05/23 | 6,064 | 6,130 | 6,049 | 6,066 | -8 | -0.1% | 795,700 |
2017/05/22 | 6,099 | 6,108 | 6,010 | 6,074 | -54 | -0.9% | 1,194,300 |
2017/05/19 | 6,171 | 6,179 | 6,116 | 6,128 | -44 | -0.7% | 869,200 |
2017/05/18 | 6,170 | 6,239 | 6,118 | 6,172 | -24 | -0.4% | 919,000 |
2017/05/17 | 6,148 | 6,208 | 6,116 | 6,196 | +9 | +0.1% | 1,020,800 |
2017/05/16 | 6,169 | 6,200 | 6,150 | 6,187 | +21 | +0.3% | 945,700 |
2017/05/15 | 6,123 | 6,202 | 6,109 | 6,166 | -3 | ±0% | 867,200 |
2017/05/12 | 6,176 | 6,215 | 6,118 | 6,169 | +45 | +0.7% | 1,603,600 |
2017/05/11 | 6,173 | 6,203 | 6,073 | 6,124 | -59 | -1% | 1,458,500 |
2017/05/10 | 6,080 | 6,193 | 6,065 | 6,183 | +138 | +2.3% | 1,372,300 |
2017/05/09 | 6,052 | 6,088 | 6,012 | 6,045 | -34 | -0.6% | 1,254,700 |
2017/05/08 | 5,970 | 6,097 | 5,943 | 6,079 | +226 | +3.9% | 2,174,300 |
2017/05/02 | 5,795 | 5,858 | 5,782 | 5,853 | +77 | +1.3% | 876,100 |
2017/05/01 | 5,733 | 5,789 | 5,715 | 5,776 | +43 | +0.8% | 824,500 |
2017/04/28 | 5,673 | 5,775 | 5,672 | 5,733 | +47 | +0.8% | 875,400 |
1801~
1850
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム